. 2023 Oct 1;15(10):e46318. doi: 10.7759/cureus.46318

Table 4. Evaluation of the effects of inflammation indexes on 30-day, 1-year mortality, and survivors (pairwise multiple comparison).

*p <0.05 denotes statistical significance. **Multiple comparison: Groups compared pairwise.

PIV^Preop: Preoperative pan immune-inflammation value; PIV^1st: Pan immune-inflammation value postoperative 1st day; PIV^3rd: Pan immune-inflammation value postoperative 3rd day; SII^Preop: Preoperative systemic immune-inflammation index; SII^1st: Systemic immune-inflammation index postoperative 1st day; SII^3rd: Systemic immune-inflammation index postoperative 3rd day; NLR^Preop: Neutrophil-lymphocyte ratio preoperative; NLR^1st: Neutrophil-lymphocyte ratio postoperative 1st day; NLR^3rd: Neutrophil-lymphocyte ratio postoperative 3rd day.

	30-day Mortality (Group 1)	30-365 day Mortality (Group 2)	Survivors (Group 3)
	Median (Min/Max)	Median (Min/Max)	Median (Min-Max)	P*	Multiple Comparison**
Age	83.20 ± 6.83	80.41 ± 9.24	77.48 ±9.00	0.06	Group1-2 (P=0.00)
PIV^Preop	520.4 (20.71-5376.6)	616.2 (56.07-9957.9)	446.3 (27.84-17442)	0.064
PIV^1st	541.0 (24.57-6102.42)	807.9 (147.5-21229.7)	707.9 (48.96-36500)	0.434
PIV^3rd	386.9 (45.73-8340.55)	784.3 (168.75-8140.2)	585.5 (65.11-9887.3)	0.638
SII^Preop	1019.4 (230.12-5974)	1032 (193.25-11000)	763.1 (180.27-19380)	0.048	Group 2-3 (P=0.01)
SII^1st	1174.5 (557.7-6780.4)	1163.1 (295-15164)	1152.6 (163.20-18684.0)	0.795
SII^3rd	1138.5 (457.25-8970)	1161 (120.3-12503.3)	1026.6 (162.7-12183.3)	0.295
NLR^Preop	4.06 (1.41-37)	5.04 (1.76-33.33)	3.53 (1.02-60)	0.017	Group 2-3 (P=0.01)
NLR^1st	6.4 (3.46-18.86)	6.30 (2.11-49.23)	5.84 (0.80-86.5)	0.415
NLR^3rd	6.8 (4.8-27.6)	5.77 (2-141.54)	5.11 (1.02-56.67)	0.006	Group 2-3 (P=0.01)
MLR^Preop	0.293 (0.03-2)	0.29 (0.17-3.5)	0.33 (0.07-4.5)	0.005	Group 2-3 (P=0.00)
MLR^1st	0.348 (0.8-2.83)	0.55 (0.20-5)	0.50 (0.12-5.89)	0.107
MLR^3rd	0.312 (0.18-1.68)	0.46 (0.20-5.21)	0.47 (0.10-3.30)	0.950